SCHEMBL4846633

SCHEMBL4846633

COc1ccc(-c2nc(C)no2)c(NS(=O)(=O)c2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC20A2 Q08357 1/20 0.49
SLC20A1 Q8WUM9 1/20 0.49
USP2 O75604 1/20 0.48
USP8 P40818 1/20 0.48
PLAU P00749 1/20 0.48
PLAT P00750 1/20 0.48
SLC40A1 Q9NP59 1/20 0.45
NR3C1 P04150 1/20 0.44
PGR P06401 1/20 0.44
AR P10275 1/20 0.44
ESR2 Q92731 1/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
AXL P30530 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
IDH2 P48735 2/20 0.43
GSK3B P49841 1/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775594 0.93 SLC20A2 (0.51) SLC20A2SLC20A1USP2USP8PLAU
SCHEMBL6378305 0.88 GAA (0.43) SLC20A2SLC20A1USP2USP8PLAU
SCHEMBL4780564 0.88 AXL (0.47) SLC40A1MEN1GAAKMT2AAXL
SCHEMBL30304724 0.88 AXL (0.47) SLC40A1MEN1GAAKMT2AAXL
SCHEMBL31478890 0.86 MEN1 (0.55) SLC40A1NR3C1PGRARESR2
SCHEMBL4726823 0.86 MEN1 (0.55) SLC40A1NR3C1PGRARESR2
SCHEMBL18051609 0.84 NR1H4 (0.44) SLC20A2SLC20A1PLAUPLATGAA
SCHEMBL4777459 0.83 LMNA (0.45) SLC40A1MEN1GAAKMT2ALMNA
SCHEMBL4779284 0.82 AXL (0.51) SLC20A2SLC20A1USP2USP8PLAU
SCHEMBL5565243 0.80 MEN1 (0.52) SLC20A2SLC20A1USP2USP8SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008008374-A2 CCR2 INHIBITORS AND METHODS OF USE THEREOF CHEMOCENTRYX, INC. (US) 2008-01-17 WO disclosed